Literature DB >> 26892846

Relationship between white matter integrity and serum cortisol levels in drug-naive patients with major depressive disorder: diffusion tensor imaging study using tract-based spatial statistics.

Xiaodan Liu1, Keita Watanabe1, Shingo Kakeda2, Reiji Yoshimura1, Osamu Abe1, Satoru Ide1, Kenji Hayashi1, Asuka Katsuki1, Wakako Umene-Nakano1, Rieko Watanabe1, Issei Ueda1, Jun Nakamura1, Yukunori Korogi1.   

Abstract

BACKGROUND: Higher daytime cortisol levels because of a hyperactive hypothalamic-pituitary-adrenal axis have been reported in patients with major depressive disorder (MDD). The elevated glucocorticoids inhibit the proliferation of the oligodendrocytes that are responsible for myelinating the axons of white matter fibre tracts. AIMS: To evaluate the relationship between white matter integrity and serum cortisol levels during a first depressive episode in drug-naive patients with MDD (MDD group) using a tract-based spatial statistics (TBSS) method.
METHOD: The MDD group (n = 29) and a healthy control group (n = 47) underwent diffusion tensor imaging (DTI) scans and an analysis was conducted using TBSS. Morning blood samples were obtained from both groups for cortisol measurement.
RESULTS: Compared with the controls, the MDD group had significantly reduced fractional anisotropy values (P<0.05, family-wise error (FWE)-corrected) in the inferior fronto-occipital fasciculus, uncinate fasciculus and anterior thalamic radiation. The fractional anisotropy values of the inferior fronto-occipital fasciculus, uncinate fasciculus and anterior thalamic radiation had significantly negative correlations with the serum cortisol levels in the MDD group (P<0.05, FWE-corrected).
CONCLUSIONS: Our findings indicate that the elevated cortisol levels in the MDD group may injure the white matter integrity in the frontal-subcortical and frontal-limbic circuits. © The Royal College of Psychiatrists 2016.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26892846     DOI: 10.1192/bjp.bp.114.155689

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN: 0007-1250            Impact factor:   9.319


  16 in total

1.  Comparison of two different analysis approaches for DTI free-water corrected and uncorrected maps in the study of white matter microstructural integrity in individuals with depression.

Authors:  Maurizio Bergamino; Rayus Kuplicki; Teresa A Victor; Yoon-Hee Cha; Martin P Paulus
Journal:  Hum Brain Mapp       Date:  2017-06-20       Impact factor: 5.038

2.  Fractional anisotropy and peripheral cytokine concentrations in outpatients with depressive episode: a diffusion tensor imaging observational study.

Authors:  Gebhard Sammer; Elena Neumann; Carlo Blecker; Bruno Pedraz-Petrozzi
Journal:  Sci Rep       Date:  2022-10-19       Impact factor: 4.996

3.  Reduced fractional anisotropy in depressed patients due to childhood maltreatment rather than diagnosis.

Authors:  Susanne Meinert; Jonathan Repple; Igor Nenadic; Axel Krug; Andreas Jansen; Dominik Grotegerd; Katharina Förster; Verena Enneking; Katharina Dohm; Simon Schmitt; Frederike Stein; Katharina Brosch; Tina Meller; Ronny Redlich; Joscha Böhnlein; Lisa Sindermann; Janik Goltermann; Elisabeth J Leehr; Nils Opel; Leni Aldermann; Andreas Reuter; Ricarda I Schubotz; Tim Hahn; Tilo Kircher; Udo Dannlowski
Journal:  Neuropsychopharmacology       Date:  2019-08-05       Impact factor: 7.853

4.  Replicable association between human cytomegalovirus infection and reduced white matter fractional anisotropy in major depressive disorder.

Authors:  Haixia Zheng; Maurizio Bergamino; Bart N Ford; Rayus Kuplicki; Fang-Cheng Yeh; Jerzy Bodurka; Kaiping Burrows; Peter W Hunt; T Kent Teague; Michael R Irwin; Robert H Yolken; Martin P Paulus; Jonathan Savitz
Journal:  Neuropsychopharmacology       Date:  2021-01-26       Impact factor: 7.853

5.  Effects of a Polymorphism of the Neuronal Amino Acid Transporter SLC6A15 Gene on Structural Integrity of White Matter Tracts in Major Depressive Disorder.

Authors:  Sunyoung Choi; Kyu-Man Han; June Kang; Eunsoo Won; Hun Soo Chang; Woo Suk Tae; Kyu Ri Son; Su-Jin Kim; Min-Soo Lee; Byung-Joo Ham
Journal:  PLoS One       Date:  2016-10-10       Impact factor: 3.240

6.  MRI-Based Classification Models in Prediction of Mild Cognitive Impairment and Dementia in Late-Life Depression.

Authors:  Aleksandra K Lebedeva; Eric Westman; Tom Borza; Mona K Beyer; Knut Engedal; Dag Aarsland; Geir Selbaek; Asta K Haberg
Journal:  Front Aging Neurosci       Date:  2017-02-02       Impact factor: 5.750

7.  Relationship between white matter integrity and serum inflammatory cytokine levels in drug-naive patients with major depressive disorder: diffusion tensor imaging study using tract-based spatial statistics.

Authors:  Koichiro Sugimoto; Shingo Kakeda; Keita Watanabe; Asuka Katsuki; Issei Ueda; Natsuki Igata; Ryohei Igata; Osamu Abe; Reiji Yoshimura; Yukunori Korogi
Journal:  Transl Psychiatry       Date:  2018-08-01       Impact factor: 6.222

8.  Corticosterone Administration Alters White Matter Tract Structure and Reduces Gliosis in the Sub-Acute Phase of Experimental Stroke.

Authors:  Katarzyna Zalewska; Rebecca J Hood; Giovanni Pietrogrande; Sonia Sanchez-Bezanilla; Lin Kooi Ong; Sarah J Johnson; Kaylene M Young; Michael Nilsson; Frederick R Walker
Journal:  Int J Mol Sci       Date:  2021-06-22       Impact factor: 5.923

9.  Relationship between interleukin (IL)-6 and brain morphology in drug-naïve, first-episode major depressive disorder using surface-based morphometry.

Authors:  Shingo Kakeda; Keita Watanabe; Asuka Katsuki; Koichiro Sugimoto; Natsuki Igata; Issei Ueda; Ryohei Igata; Osamu Abe; Reiji Yoshimura; Yukunori Korogi
Journal:  Sci Rep       Date:  2018-07-03       Impact factor: 4.379

10.  Circulating cortisol and cognitive and structural brain measures: The Framingham Heart Study.

Authors:  Justin B Echouffo-Tcheugui; Sarah C Conner; Jayandra J Himali; Pauline Maillard; Charles S DeCarli; Alexa S Beiser; Ramachandran S Vasan; Sudha Seshadri
Journal:  Neurology       Date:  2018-10-24       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.